4.7 Article

LncRNA GATA3-AS1 facilitates tumour progression and immune escape in triple-negative breast cancer through destabilization of GATA3 but stabilization of PD-L1

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Long non-coding RNA EPIC1 inhibits viability and invasion of osteosarcoma cells by promoting MEF2D ubiquitylation

Wei Zhao et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)

Article Immunology

Divergent IncRNA GATA3-AS1 Regulates GATA3 Transcription in T-Helper 2 Cells

Hunter R. Gibbons et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Medicine, Research & Experimental

Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge, Napoli, November 30th 2016

Paolo A. Ascierto et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2017)

Review Oncology

Long Noncoding RNA and Cancer: A New Paradigm

Arunoday Bhan et al.

CANCER RESEARCH (2017)

Article Oncology

Deubiquitination and Stabilization of PD-L1 by CSN5

Seung-Oe Lim et al.

CANCER CELL (2016)

Review Biochemistry & Molecular Biology

The emerging role of IncRNAs in cancer

Maite Huarte

NATURE MEDICINE (2015)

Review Oncology

Breast cancer in China

Lei Fan et al.

LANCET ONCOLOGY (2014)

Letter Allergy

Profiling of human CD4+ T-cell subsets identifies the TH2-specific noncoding RNA GATA3-AS1

Huan Zhang et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)

Review Biochemistry & Molecular Biology

Long non-coding RNAs and cancer: a new frontier of translational research?

R. Spizzo et al.

ONCOGENE (2012)

Review Cell Biology

Long noncoding RNAs and human disease

Orly Wapinski et al.

TRENDS IN CELL BIOLOGY (2011)

Review Cell Biology

Long noncoding RNAs: functional surprises from the RNA world

Jeremy E. Wilusz et al.

GENES & DEVELOPMENT (2009)